BridgeBio has substantially improved its development of the novel solution for amyloid heart disease, utilizing the compound. Initial patient results suggests significant benefits for patients diagnosed by this severe disease. The effort underscores BridgeBio's commitment to managing unmet healthcare needs in the cardiology space. Attruby: BridgeB